ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $817,000 | -9.6% | 14,200 | 0.0% | 1.09% | -10.2% |
| Q1 2015 | $904,000 | -0.4% | 14,200 | -3.4% | 1.22% | -4.3% |
| Q4 2014 | $908,000 | +62.4% | 14,700 | +2.1% | 1.27% | +51.2% |
| Q3 2014 | $559,000 | +160.0% | 14,400 | +130.4% | 0.84% | +164.8% |
| Q2 2014 | $215,000 | -68.3% | 6,250 | -60.2% | 0.32% | -70.2% |
| Q1 2014 | $678,000 | -45.3% | 15,700 | -49.5% | 1.07% | -16.5% |
| Q4 2013 | $1,239,000 | +32.2% | 31,100 | +24.6% | 1.28% | +22.9% |
| Q3 2013 | $937,000 | – | 24,950 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |